Report Categories
View AllRecent Articles
View All
BioAffinity BIAF Stock Slides Breakdown Watch 20260416
Archer ACHR Stock Good Investment Now 049 20260418
Market Recap Tech leads gains as consumer names lag the market
Iron IRM Q1 earnings surge 15 percent above estimates as data storage demand accelerates shares rise
CartesianIII CGCTU Stock Why It Matters This Year Grinds Higher 20260423
Compugen CGEN Stock Good Entry Point 124 20260420
Dow Inc DOW
Gold and Silver Rebound as Bond Yields Stabilize Middle East Tensions Linger
Greg Abel Overhauls Berkshire Hathaway Portfolio Exits Major Holdings Triples Alphabet Stake
C3is CISS Q3 2025 Earnings EPS 058 In Line with Estimates
AARP Partners with North Carolina Law Enforcement to Combat Cryptocurrency ATM Scams
Enliven Therapeutics ELVN Slips 315 Testing 4008 Support 20260514
Trumps Latin American Strategy Reshapes Regional Trade Dynamics Reducing Chinas Footprint
SpaceX Delays Starship Launch Amid Potential RecordBreaking IPO Plans
Hindalco Reports 50 Drop in Q4 Net Profit Due to OneTime Expense of 4171 Crore at Novelis
Sportradar CFO and CEO Named in Lawsuit Over Alleged Illegal Gambling Ties
Indian Bond Bull Market Poised for Pause but Not End Expert Suggests
Bloom Energy Surges 12 on 26 Billion Partnership with European AI Infrastructure Firm Nebius
Dow Hits Record Close as AI Rally Pauses SP 500 Nasdaq Flat
RCI Hospitality Holdings RICK Q3 2025 Earnings EPS Misses Estimates by a Wide Margin
PG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains 317
Tenet Healthcare Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction
IRM Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction
BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility
VNDA Q1 2026 Earnings EPS Misses Estimates as Losses Widen Stock Slides
Pulmonx LUNG Edges Higher as Stock Tests Key Technical Levels
Serina Therapeutics Inc SER Gains Nearly 5 as Stock Approaches Key Resistance
Chart Industries Holds Steady Near 208 as Traders Assess Support and Resistance
DeFi Development Corp DFDV Posts Marginal Gain as Price Hovers Between Key Levels
Fate Therapeutics Rallies 95 as FATE Stock Breaks Above Key Support Level